Shares of Sorrento Therapeutics (SRNE) rose by a staggering 25.97% in 30 days from $6.93 to $8.73 at 20:52 EST on Thursday, after four consecutive sessions in a row of gains. NASDAQ Composite (SRNE) is rising 0.78% to $14,020.33, following the last session’s upward trend,
Sorrento Therapeutics’s last close was $9.00, 53.58% below its 52-week high of $19.39.
Today’s last reported volume for Sorrento Therapeutics is 4947309 which is 32.52% below its average volume of 7331228.
Sorrento Therapeutics’s Sales
Sorrento Therapeutics’s sales growth is 93.1% for the present quarter and 98.6% for the next. The company’s growth estimates for the ongoing quarter and the next is 200% and 221.2%, respectively.
Sorrento Therapeutics’s Revenue
Year-on-year quarterly revenue growth declined by 11.7%, now sitting on 39.99M for the twelve trailing months.
Sorrento Therapeutics’s last week, last month’s, and last quarter’s current volatility was 3.14%, 0.72%, and 3.71%, respectively.
Sorrento Therapeutics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 7.34% (last week), 3.69% (last month), and 3.71% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Sorrento Therapeutics’s stock is considered to be oversold (<=20).
Sorrento Therapeutics’s Stock Yearly Top and Bottom Value
Sorrento Therapeutics’s stock is valued at $8.73 at 20:52 EST, way under its 52-week high of $19.39 and way above its 52-week low of $4.31.
Sorrento Therapeutics’s Moving Average
Sorrento Therapeutics’s value is way higher than its 50-day moving average of $7.60 and under its 200-day moving average of $8.91.
More news about Sorrento Therapeutics (SRNE).